Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Myeloproliferative disorders].

D Binder1, J Fehr

  • 1Hämatologisches Zentrallabor, Kantonsspital Winterthur, Winterthur.

Therapeutische Umschau. Revue Therapeutique
|March 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term trajectories of densely reported depressive symptoms during an extended period of the COVID-19 pandemic in Switzerland: Social worries matter.

Comprehensive psychiatry·2024
Same author

CAD4TB software updates: different triaging thresholds require caution by users and regulation by authorities.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

Evaluation of a measles vaccination campaign at the universities in the city of Zurich, 2019.

Public health·2021
Same author

A systematic review and meta-analysis of first-line tuberculosis drug concentrations and treatment outcomes.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020
Same author

Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals.

Vaccine·2020
Same author

Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017.

HIV medicine·2019
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Myeloproliferative neoplasms stem from abnormal blood stem cells, causing uncontrolled cell growth. This review covers key aspects of polycythemia vera, essential thrombocythemia, and chronic idiopathic myelofibrosis.

Area of Science:

  • Hematology
  • Oncology
  • Stem Cell Biology

Context:

  • Myeloproliferative neoplasms (MPNs) arise from clonal abnormalities in hematopoietic stem cells.
  • These disorders are characterized by uncontrolled proliferation of one or more blood cell lines.
  • MPNs share common clinical and hematologic features, including clonal hematopoiesis and genetic instability.

Purpose:

  • To review the clinical and prognostic aspects of major MPNs.
  • To discuss current diagnostic procedures for MPNs.
  • To outline therapeutic strategies for MPNs.

Summary:

  • This review focuses on polycythemia vera, essential thrombocythemia, and chronic idiopathic myelofibrosis.
  • It details their shared characteristics, such as stem cell abnormalities and genetic instability.

Related Experiment Videos

  • The review also covers their distinct clinical presentations, prognoses, and management.

    • Impact:

    • Provides a comprehensive overview of key myeloproliferative neoplasms.
    • Aids clinicians in diagnosing and managing patients with these disorders.
    • Informs understanding of disease progression and transformation risks into acute leukemia.